This program was presented in partnership with White Plains Hospital
Endocrine therapies are commonly used to treat breast cancer that is estrogen-receptor positive. To name a few: Tamoxifen, Evista (Raloxifene) Arimidex (Anastrazole), Aromasin (Exemestane), Femara (Letrozole), Fulvestrant(Faslodex). Endocrine therapies may be used at different points in a treatment plan and to treat various stages of breast cancer.
- Endocrine therapy options
- Different contexts for use
- The latest updates
- Supportive care and management of side-effects
Instructor: Dr. Karen Green, Medical Oncologist at White Plains Hospital in White Plains, NY graduated from New York University School of Medicine, where she was elected to the Alpha Omega Alpha Honor Medical Society and received the NYU Alumnae Club Award for the outstanding woman medical student. She was a resident in internal medicine and fellow in hematology/oncology at New York Hospital-Cornell Medical Center. After serving on the full-time faculty at the Weill Cornell Medical College for eight years where she specialized in breast cancer, she joined White Plains Hospital in 2003. She continues to focus her practice on breast cancer, and she also treats patients with a wide range of other types of cancer and benign blood disorders. At White Plains Hospital, she is the site principal investigator for the ECOG-ACRIN Cancer Research Group, and she is also the principal investigator or a co-investigator on a number of clinical trials. She serves on the White Plains Hospital Institutional Review Board and is a member of the White Plains Hospital Breast Program Leadership. She is an active member of the American Society of Clinical Oncology and the New York Metropolitan Breast Cancer Group.